Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Uterus and Cervix01:18

Uterus and Cervix

The uterus, commonly called the womb, is a vital reproductive organ in females designed to provide a nurturing environment for the implantation and growth of an embryo. It is shaped like a hollow pear and positioned between the urinary bladder and the rectum. The uterus's structure allows it to support and protect a developing fetus throughout pregnancy.
The uterus is securely anchored within the pelvic cavity by paired broad ligaments on either side. It is further stabilized by three pairs of...
Uterine Tubes01:16

Uterine Tubes

The uterine or fallopian tubes function as the conduit through which oocytes travel from the ovaries to the uterus. Each fallopian tube measures approximately 10 to 13 cm long and is anatomically divided into the infundibulum, ampulla, isthmus, and interstitial part (or intramural segment). The infundibulum is characterized by its funnel shape and features extensions called fimbriae which reach towards the peritoneal cavity. These fimbriae play a critical role during ovulation as they extend...
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intraoperative Rupture of the Ovarian Capsule in Early-Stage Ovarian Cancer: A Meta-analysis.

Obstetrics and gynecology·2021
Same author

Disparities in Access to High-Volume Surgeons Within High-Volume Hospitals for Hysterectomy.

Obstetrics and gynecology·2021
Same author

Paradigm shift from tubal ligation to opportunistic salpingectomy at cesarean delivery in the United States.

American journal of obstetrics and gynecology·2021
Same author

Use and outcomes of neoadjuvant chemotherapy for metastatic uterine cancer.

Gynecologic oncology·2021
Same author

Maternal morbidity and mortality associated with epilepsy.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·2021
Same author

Correlation of surgical case volume and fellowship training with performance on simulated procedural tasks.

American journal of obstetrics and gynecology·2021
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Related Experiment Video

Updated: May 31, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

Uterine carcinosarcoma.

Rebecca Arend1, Janine A Doneza, Jason D Wright

  • 1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA.

Current Opinion in Oncology
|July 12, 2011
PubMed
Summary
This summary is machine-generated.

Uterine carcinosarcomas are aggressive cancers with a poor prognosis. Research is ongoing to find the best adjuvant treatments, as surgery alone may not be enough.

Related Experiment Videos

Last Updated: May 31, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

Area of Science:

  • Gynecologic Oncology
  • Surgical Pathology

Background:

  • Uterine carcinosarcomas are rare but aggressive uterine neoplasms.
  • These tumors are associated with a poor prognosis, even in early stages.

Purpose of the Study:

  • To review the clinical characteristics of uterine carcinosarcoma.
  • To summarize the epidemiology of uterine carcinosarcoma.
  • To outline current and emerging treatment strategies for uterine carcinosarcoma.

Main Methods:

  • Literature review of recent studies on uterine carcinosarcoma.
  • Analysis of clinical data, epidemiological trends, and treatment outcomes.
  • Synthesis of findings on surgical, radiation, and chemotherapeutic interventions.

Main Results:

  • Uterine carcinosarcomas exhibit aggressive behavior and a poor prognosis.
  • Surgical intervention is the primary treatment modality.
  • The optimal adjuvant therapy, including radiation and chemotherapy, is still under investigation.

Conclusions:

  • Uterine carcinosarcoma is a highly aggressive malignancy.
  • Ongoing studies aim to establish the most effective adjuvant therapies to improve patient outcomes.